Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117379) titled 'Evaluation of the Efficacy of Digital Neuromodulation Software in Improving Cognitive Symptoms of Depression and Research on the Related Immune-Inflammatory Mechanisms' on Jan. 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Anding Hospital, Capital Medical University
Condition:
Depression
Intervention:
Control group:The control group received systematic treatment with a single type of SSRI or SNRI antidepressant as usual.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-23
Target Sample Size: Control group:35;Cognitive Training Grou...